InvestorsHub Logo
Followers 41
Posts 5379
Boards Moderated 0
Alias Born 11/15/2013

Re: JKS3 post# 402903

Saturday, 02/11/2023 5:32:02 PM

Saturday, February 11, 2023 5:32:02 PM

Post# of 460095
ANAVEX®2-73 (BLARCAMESINE) PHASE 2B/3 STUDY MET PRIMARY AND KEY SECONDARY ENDPOINTS,

SHOWING STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN GLOBAL CLINICAL STUDY OF PATIENTS WITH EARLY ALZHEIMER’S DISEASE

AVXL trial successful. Sound familiar..
Bullish
Bullish

Freedom is not free.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News